Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $1.5M |
| Gross profit | $0 | −$1.5M |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$3.8K | −$1.5M |
| EBITDA | −$3.8K | $5.4M |
| Net income | −$3.7K | $4.9M |
| Net margin | — | — |
| EPS (diluted) | -0.00 | 0.29 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ITAQ.
No tracked institution reports a position in ITAQ as of their last filing.
No one on the platform has traded ITAQ yet.
| -1.44% |
| $62M |
| — |
| GAMCGolden Arrow Merger Corp. | $9.00 | -22.41% | $69M | — |
| HAIAHealthcare AI Acquisition Corp. | $10.86 | +100.00% | $63M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.